Based on the relationship between Ang-2 and LVD in CMM, we speculate that Ang-2 may promote tumor-associated lymphangiogenesis, and these results may indicate the feasibility of a new prognostic indicator and a new strategy for the clinical treatment of CMM. The gene discussed is ANGPT2; the disease is familial congenital mirror movements.